WFF-15734-51591 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-09-15
Dose 1 — Pfizer-BioNTech
2022-10-06
Registered in v-safe
2022-10-06
Dose 2 — Pfizer-BioNTech
Co-administered: Flu
2022-10-06
Health check-in — day 0, dose 2, under 3
Feeling: Fair · Site: Pain · Irritability/crying

Under 3 check-in
2022-10-09
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Good · None

Under 3 check-in
2022-10-10
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Good · None

Under 3 check-in
2022-10-11
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Good · None

Under 3 check-in
2022-10-13
Health check-in — day 7, dose 2, under 3
Feeling: Good · None

Under 3 check-in
2022-10-22
Health check-in — day 14, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-10-28
Health check-in — day 21, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-11-03
Health check-in — day 28, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-11-11
Health check-in — day 35, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-11-17
Survey response — day 42, dose 2, under 3
MedDRA: Diarrhoea — Feeling: Poor · Be unable to do your normal daily activities

Free text: diarrhea

MedDRA releases: 2024-11 · check-in free text available
2023-01-05
Survey response — 3 months, dose 2, under 3
MedDRA: COVID-19 — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

MedDRA releases: 2024-11
2023-01-05
Report sent to call center — 3 months, dose 2, under 3
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · 1 call case(s)
2023-01-06
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-09-15	Pfizer-BioNTech	No
2	2022-10-06	Pfizer-BioNTech	Flu

Call center

Reported	Outcome	VAERS-related outcome
2023-01-05	Successful 2023-01-06	Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Free text

Release 12 (Under 3) — day 42, dose 2, under 3

2022-11-17

Symptoms: diarrhea

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	COVID-19	·	·	✓
SD	Diarrhoea	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release